Algeta ASA
oslo : ALGETA

May 15, 2013 01:13 ET

Algeta ASA : Changes in Algeta's Financial Calendar 2013

OSLO, NORWAY--(Marketwired - May 15, 2013) -

Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces changes to its financial calendar for 2013.

New dates are as follows:

2(nd) Quarter Results 2013: 28 August 2013

3(rd) Quarter Results 2013: 6 November 2013

All dates are tentative and could be subject to change.

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

Press release: http://hugin.info/134655/R/1701819/562060.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1701819]

Contact Information

  • For further information, please contact

    Mike Booth
    Communications & Corporate Affairs
    +47 2202 4510
    Email Contact

    Media enquiries:

    Mark Swallow
    Citigate Dewe Rogerson
    +44 207 638 9571
    Email Contact

    Knut Ekern
    Gambit Hill & Knowlton
    +47 22 04 82 00
    Email Contact

    Kari Watson
    MacDougall Biomedical Communications
    +1 781 235 3060
    Email Contact

    US investor enquiries:

    Tricia Swanson
    The Trout Group
    +1 646 378 2953
    Email Contact